PCR Journal Club

The PCR Journal Club provides a selection of Literature Reviews of top interventional cardiovascular journals world-wide, selected and commented by the PCR Journal Club team.

Filter By

297 results

Switching of oral anticoagulation therapy after PCI in patients with atrial fibrillation: The RE-DUAL PCI trial subanalysis

16 Dec 2019

The objective of this substudy was to examine the safety of switching patients with atrial fibrillation (AF) who were previously on warfarin or a direct oral anticoagulant (DOAC) to dabigatran dual therapy.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
The RE-DUAL PCI Trial Subanalysis

Large-scale assessment of a Smartwatch to identify atrial fibrillation

16 Dec 2019

The study aimed to evaluate the capabilities of correctly detecting episodes of Atrial fibrillation/flutter (Afib) through a smartwatch-based irregular pulse notification algorithm of the Apple watch.

Luigi Biasco

Reviewer

Luigi Biasco
Large-scale assessment of a Smartwatch to identify atrial fibrillation

A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)

13 Dec 2019

The GALILEO trial was a randomized, open-label, event-driven, international, multicentre trial comparing two different preventive strategies for thromboembolic complications in patients who underwent successful TAVI and had not established indication for oral anticoagulation.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Eduardo Bahena-López

Reviewer

Eduardo Bahena-López
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

Efficacy and safety of low-dose colchicine after myocardial infarction (COLCOT)

09 Dec 2019

COLCOT was a double-blind RCT, designed to evaluate 0.5 mg oral colchicine daily as compared with placebo in patients within 30 days of acute myocardial infarction.

Arturo Giacaman

Reviewer

Arturo Giacaman

Reviewer

Christopher Cook
Efficacy and safety of low-dose colchicine after myocardial infarction

Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease

06 Dec 2019

This study compared the outcomes of TAVR in patients with pure Aortic Stenosis (i.e., without or trivial AR) vs. patients with MAVD (AS associated with mild to moderate or severe AR).

Babu Ezhumalai

Reviewer

Babu Ezhumalai

Reviewer

Salvatore Brugaletta
Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease

Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis

05 Dec 2019

Although multiple studies have demonstrated an early health status benefit with TAVI vs. SAVR , this is the first randomized trial to demonstrate a persistent, albeit modest, health status advantage with TAVI at 6 and 12 months—timepoints at which patients are assumed to have recovered fully...

Reviewer

Salvatore Brugaletta
Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis

Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses

03 Dec 2019

The results of this study suggest that the use of self-expandable valves could help reduce the incidence of post-procedural PPM after TAVI, especially in the population with large body size...

Reviewer

Romain Didier
Souheib Feliachi

Reviewer

Souheib Feliachi
Prosthesis-patient mismatch following TAVR with supra-annular and intra-annular prostheses

Reduced leaflet motion after transcatheter aortic-valve replacement

27 Nov 2019

The GALILEO-4D was a dedicated substudy that sought to evaluate the effect of oral anticoagulation with rivaroxaban on bioprosthetic aortic valve leaflet thickening and motion impairment.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Antonio H. Frangieh

Reviewer

Antonio H. Frangieh
Reduced leaflet motion after transcatheter aortic-valve replacement

One-year outcomes of angina management guided by invasive coronary function testing (CorMicA)

27 Nov 2019

CorMicA was a randomised control trial comparing medical therapy guided by invasive coronary function testing (CFR, IMR and acetylcholine provocation) versus standard care in 151 patients with symptoms and/or signs of ischaemia with no obstructive coronary artery disease (INOCA).

Nicola Ryan

Reviewer

Nicola Ryan
Dejan Milasinovic

Reviewer

Dejan Milasinovic
One-year outcomes of angina management guided by invasive coronary function testing (CorMicA)

Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement

05 Dec 2019

Using the data from the national prospective French registry (FRANCE TAVI), this study compared the characteristics and outcomes of TAVR procedures according to whether they were performed through a femoral or a nonfemoral peripheral access.

Reviewer

Salvatore Brugaletta
Femoral vs nonfemoral peripheral access for transcatheter aortic valve replacement